Raloxifene Hydrochloride Market to Surpass USD 4.4 Billion by 2035, Driven by Rising Osteoporosis Cases and Growing Focus on Women's Health
The global Raloxifene Hydrochloride Market is witnessing steady growth as healthcare providers increasingly emphasize preventive care and long-term management of osteoporosis and breast cancer risk among postmenopausal women. Rising awareness regarding women's health, expanding geriatric populations, and continuous advancements in pharmaceutical research are driving the adoption of raloxifene...
0 Hozzászólás
0 Megosztás
9 Nézettség